מרכז רפואי העמק הוא בית חולים הממוקם בין גבעת המורה לעפולה. בית החולים החל לפעול תחת אחריות קופת חולים כללית בשנת 1924 ונחנך במיקומו הנוכחי ב-20 במרץ 1930. מרכז רפואי העמק מספק מגוון רחב של שירותים, חדרי ניתוח משוכללים, יחידות טיפול נמרץ, מכונים ומעבדות.

During the past decade, Ha'Emek Medical Center conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 36 clinical trials were completed, i.e. on average, 22.9% percent of trials that started reached the finish line to date. In the past 5 years, 75 clinical trials started and 29 clinical trials were completed. i.e. 38.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ha'Emek Medical Center" #1 sponsor was "HaEmek Medical Center, Israel" with 98 trials, followed by "Janssen Research & Development, LLC" with 10 trials sponsored, "Takeda" with 6 trials sponsored, "Bayer" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ha'Emek Medical Center" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Weizmann Institute of Science" with 3 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Ha'Emek Medical Center" are "Crohn's Disease" (9 trials), "Schizophrenia" (6 trials), "Crohn Disease" (5 trials), "Colitis, Ulcerative" (4 trials) and "Infertility" (4 trials). Many other conditions were trialed in "Ha'Emek Medical Center" in a lesser frequency.

Most popular intervention types in "Ha'Emek Medical Center" are "Drug" (130 trials), "Other" (41 trials), "Device" (27 trials), "Diagnostic Test" (10 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Etrasimod" (4 trials), "Lenalidomide" (4 trials), "Apixaban" (3 trials) and "C-Scan System" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ha'Emek Medical Center" are 202 trials for "All" genders, 40 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 71 active trials in "Ha'Emek Medical Center". 3 are not yet recruiting, 49 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 109 completed trials in Ha'Emek Medical Center, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Ha'Emek Medical Center, 8 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 65 trials that are defined as “Not Applicable".

Ha'Emek Medical Center has several departments that took part in Clinical trials: "Pediatric Hematology Unit - HaEmek Medical Center" - 40 trials, "Haemek Hospital; Gastroenterology" - 6 trials